PEMETREXED INTAS pemetrexed (as disodium) 1000 mg powder for injection vial

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

pemetrexed disodium, Quantity: 1102.9 mg (Equivalent: pemetrexed, Qty 1000 mg)

Beschikbaar vanaf:

Accord Healthcare Pty Ltd

INN (Algemene Internationale Benaming):

pemetrexed disodium

farmaceutische vorm:

Injection, powder for

Samenstelling:

Excipient Ingredients: mannitol; sodium hydroxide; hydrochloric acid

Toedieningsweg:

Intravenous

Eenheden in pakket:

1 vial per carton

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

Malignant Pleural Mesothelioma,Pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,Non-Small Cell lung Cancer,Pemetrexed in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,Pemetrexed as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Product samenvatting:

Visual Identification: A white to either light yellow or greenish yellow lyophilized solid in a clear glass vial; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Autorisatie-status:

Licence status A

Autorisatie datum:

2015-05-28